Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01402492 · ClinicalTrials.gov registry record · Phase 2
Cocaine Use Reduction With Buprenorphine
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 302
- Enrollment target
NCT01402492: Completed Phase 2 study, sponsored by University of California, Los Angeles.
NCT01402492 is a Phase 2 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 302 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (127% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01402492, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 302 participants
- Enrollment target
Study Summary
The aim of this study is to investigate the safety and effectiveness of buprenorphine in the presence of naltrexone for the treatment of cocaine dependence.
Primary Outcome
Self-reported days of cocaine use corroborated with urine drug screens (UDS).
Interventions
- DRUG Buprenorphine + Naltrexone
- DRUG Placebo + Naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
What the finished NCT01402492 record still lists
NCT01402492 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (127% higher).
The record links to 0 conditions, and to 2 interventions - of which Buprenorphine + Naltrexone is the first listed.
NCT01402492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01402492 about?
NCT01402492 is a clinical study titled "Cocaine Use Reduction With Buprenorphine". The aim of this study is to investigate the safety and effectiveness of buprenorphine in the presence of naltrexone for the treatment of cocaine dependence.
What is the current status of trial NCT01402492?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 302 participants. The study started on 2011-09. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01402492?
The interventions under investigation include: Buprenorphine + Naltrexone (DRUG), Placebo + Naltrexone (DRUG).
Who is sponsoring clinical trial NCT01402492?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01402492's enrollment target sits among peer trials
302 167th of 2000 higher than 1,834 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia